Waycross Partners, LLC Pfizer Inc Transaction History

Waycross Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $196,950 - $256,400	-5,000 Reduced 48.8%	5,245 $213,000
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $98,125 - $126,050	-2,500 Reduced 19.62%	10,245 $441,000
Q2 2021 Aug 17, 2021	BUY	$35.91 - $40.68 $324,805 - $367,950	9,045 Added 244.46%	12,745 $499,000
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $324,805 - $367,950	-9,045 Reduced 70.97%	3,700 $210,000
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $426,575 - $542,427	12,745 New	12,745 $469,000

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Waycross Partners, LLC with notifications on news.